208 related articles for article (PubMed ID: 9875582)
1. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Kemper CA; Meng TC; Nussbaum J; Chiu J; Feigal DF; Bartok AE; Leedom JM; Tilles JG; Deresinski SC; McCutchan JA
Ann Intern Med; 1992 Mar; 116(6):466-72. PubMed ID: 1739237
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
4. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Chiu J; Nussbaum J; Bozzette S; Tilles JG; Young LS; Leedom J; Heseltine PN; McCutchan JA
Ann Intern Med; 1990 Sep; 113(5):358-61. PubMed ID: 2382918
[TBL] [Abstract][Full Text] [Related]
5. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.
Kemper CA; Havlir D; Haghighat D; Dubé M; Bartok AE; Sison JP; Yao Y; Yangco B; Leedom JM; Tilles JG
J Infect Dis; 1994 Jul; 170(1):157-64. PubMed ID: 8014492
[TBL] [Abstract][Full Text] [Related]
6. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
[TBL] [Abstract][Full Text] [Related]
8. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Fournier S; Burguière AM; Flahault A; Vincent V; Treilhou MP; Eliaszewicz M
Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):16-22. PubMed ID: 10192709
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD
Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083
[TBL] [Abstract][Full Text] [Related]
10. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Horgen L; Legrand E; Rastogi N
FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
[TBL] [Abstract][Full Text] [Related]
11. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Gordon SM; Horsburgh CR; Peloquin CA; Havlik JA; Metchock B; Heifets L; McGowan JE; Thompson SE
J Infect Dis; 1993 Dec; 168(6):1559-62. PubMed ID: 8245546
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR
Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.
Jacobson MA; Yajko D; Northfelt D; Charlebois E; Gary D; Brosgart C; Sanders CA; Hadley WK
J Infect Dis; 1993 Jul; 168(1):112-9. PubMed ID: 8515098
[TBL] [Abstract][Full Text] [Related]
14. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
de Lalla F; Maserati R; Scarpellini P; Marone P; Nicolin R; Caccamo F; Rigoli R
Antimicrob Agents Chemother; 1992 Jul; 36(7):1567-9. PubMed ID: 1387303
[TBL] [Abstract][Full Text] [Related]
16. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
Sison JP; Yao Y; Kemper CA; Hamilton JR; Brummer E; Stevens DA; Deresinski SC
J Infect Dis; 1996 Mar; 173(3):677-83. PubMed ID: 8627032
[TBL] [Abstract][Full Text] [Related]
18. Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
Olliaro P; Dautzenberg B
J Chemother; 1994 Jun; 6(3):189-96. PubMed ID: 7983502
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
Sullam PM; Gordin FM; Wynne BA
Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
Jorup-Rönström C; Julander I; Petrini B
J Infect; 1993 Jan; 26(1):67-70. PubMed ID: 8384230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
